Human-centred design forms an integral part of our work across the full market spectrum, delivering both regulatory compliance and commercial success.
It’s vital to understand the user and how they will relate to a product. Frequently, these insights provide the inspiration required to create truly innovative products.
Conducting research early in the development process yields valuable insight at a point where meaningful changes can be implemented in the design. In addition to stakeholder interviews and needs assessments, we conduct ethnographic research worldwide to uncover the tacit (unspoken) and latent (unfathomed) needs of users.
Integrating user experience development
Our human factors experts work alongside our mechanical, software, electrical and design engineers from the outset, ensuring that the needs of users and other stakeholders are considered throughout the development process.
Our integrated, human-centric approach – which considers the user, the technology and the environment as a single system – means that the end-use experience is not compromised as trade-offs are assessed and key decisions made.
Ensuring regulatory success
We partner with our clients to help them understand FDA expectations and provide guidance on human factors in medical device development.
We have a wealth of experience in supporting regulatory submissions – including use-related risk management, formative and validation assessments – ensuring that later stage requirements and expectations are considered from the outset.
Our human factors experience comes into play throughout the development process, from discovering stakeholder needs, defining product requirements and generating concepts to guiding product design and eventual assessment and validation.
Our human-centred design teams are based in both the US and UK, consisting of human factors engineers, cognitive psychologists, biomedical engineers and environmental designers.
Interested in joining us?
Tech, tools & facilities
Co-creation & co-working space
We are highly collaborative in our approach and provide dedicated co-creation facilities where we can join forces with our client teams to address the task in hand. Creative spaces throughout our offices provide a blank canvas for ad-hoc brainstorming sessions and planned workshops, inspiring our designers in their quest to develop impactful, unique and meaningful user experiences. During the long months of the pandemic, we raised the bar for remote collaboration by exploiting dynamic virtual environments to the full. Such experiences are now just as engaging and fruitful as face-to-face sessions.
Food & beverage lab
Specifically set up to meet the unique requirements of developing food- and beverage-safe systems, our dedicated lab means we have the necessary procedures and equipment in place to design and test new products in-house. Quantitative and scientific testing is fundamental to our science-led innovation approach, but ultimately taste tests are always needed. This is our only lab where the consumption of food and drink is not just allowed but essential!
Surgical innovation suite
Equipped to simulate clinical, home and office environments, this facility allows us to test concepts, evaluate prototypes and analyse workflows in a safe and confidential setting. It’s an invaluable tool for understanding and communicating the contextual implications of design decisions, while the ability to conduct quick-turnaround usability evaluations means we can efficiently progress design and development.
UX design studios
Equipped for creative, collaborative thinking, we use our UX design spaces to aggregate research data, user stories and create design concepts that remain visible for the duration of the project. Each design studio allows our project teams to develop ideas and explore designs while preserving client confidentiality.
A rapid response to help speed up vital COVID-19 testing
A visionary medical device, beautiful and effortless to use
A world-first for endovascular bleed detection
We helped Chiesi Farmaceutici create a novel, next-generation dry powder inhaler (DPI) to compete with the market leaders throughout Europe.
News & insights
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
The world is in crisis. Simple, short-term survival is everyone’s top priority, whether that’s as a nation, a government, a business, a family or a lonely and forgotten self-isolating individual. But the overwhelming necessity to endure has always been the mother of invention. Where will the crisis lead us?
- AI & Analytics
- Digital service innovation
- Human factors
- Innovation management
- Strategic advice
Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...
- AI & Analytics
- Connectivity & IoT
- Digital health
- Digital security
- Digital service innovation
- Human factors
- Product realisation
- User Experience (UX)
The menopause is seen by many to be merely a “women’s issue”. We have partnered with the National Innovation Centre for Ageing, to explore women’s experience of the menopause and to propose technology-based interventions.
The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021.
Partnership Opportunities in Drug Delivery (PODD) is back. In keeping with a proud, decade-long tradition, it combines cutting-edge business and scientific content from the drug delivery field with top-notch speakers.
Cambridge Consultants’ Head of Ophthalmology, Luis Diaz-Santana will be presenting, 'Europe as an innovation powerhouse in ophthalmology'